Formal Agreement Reached for $900 Million Sale of Pharmaceuticals Division to Aspen Pharmacare

On 16 August 2010, Sigma announced that it had agreed in principle to sell its Pharmaceuticals Division to the Aspen Pharmacare Holdings Limited group of companies for A$900 million.

On 16 August 2010, Sigma announced that it had agreed in principle to sell its Pharmaceuticals Division to the Aspen Pharmacare Holdings Limited group of companies (“Aspen”) for A$900 million.

Sigma has now reached formal agreement with Aspen on the terms and conditions of the sale and the ongoing relationship between the two companies.

Sigma Deal

Content Last Reviewed On July 16, 2018